Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,628
datasets available to search
ShareScore release 0.9.0
Dataset results
1,628 results for “type safety”
A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)
ClinicalTrials.gov study NCT03751007. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
ClinicalTrials.gov study NCT00698932. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD)
ClinicalTrials.gov study NCT03226678. IPD Sharing: NO. Countries: 1. Publications: 1.
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in
ClinicalTrials.gov study NCT01713530. IPD Sharing: Not stated. Countries: 5. Publications: 3.
Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02227849. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT03018028. IPD Sharing: YES. Countries: 1. Publications: 4.
Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00601250. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT02220907. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in B
ClinicalTrials.gov study NCT03625141. IPD Sharing: Not stated. Countries: 8. Publications: 2.
Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
ClinicalTrials.gov study NCT01365455. IPD Sharing: Not stated. Countries: 12. Publications: 9.
Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin
ClinicalTrials.gov study NCT02582242. IPD Sharing: YES. Countries: 7. Publications: 1.
Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin
ClinicalTrials.gov study NCT01210001. IPD Sharing: Not stated. Countries: 7. Publications: 4.
Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis
ClinicalTrials.gov study NCT01358578. IPD Sharing: Not stated. Countries: 23. Publications: 9.
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
ClinicalTrials.gov study NCT02531035. IPD Sharing: Not stated. Countries: 19. Publications: 1.
A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01513590. IPD Sharing: Not stated. Countries: 10. Publications: 4.
Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea
ClinicalTrials.gov study NCT01392677. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02692716. IPD Sharing: Not stated. Countries: 21. Publications: 14.
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Cont
ClinicalTrials.gov study NCT02131272. IPD Sharing: Not stated. Countries: 24. Publications: 1.
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT01029886. IPD Sharing: Not stated. Countries: 21. Publications: 2.
The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02008682. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.